Trial Profile
Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Benign prostatic hyperplasia; Gynaecological infections; Skin and soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- Acronyms ERTAPRO
- 29 Jan 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 08 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
- 08 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.